1-119385001-G-A
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4BP6_Moderate
The NM_016527.4(HAO2):c.509G>A(p.Arg170Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000136 in 1,613,776 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_016527.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HAO2 | NM_016527.4 | c.509G>A | p.Arg170Gln | missense_variant | 4/8 | ENST00000325945.4 | NP_057611.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HAO2 | ENST00000325945.4 | c.509G>A | p.Arg170Gln | missense_variant | 4/8 | 1 | NM_016527.4 | ENSP00000316339.3 | ||
HAO2 | ENST00000361035.8 | c.548G>A | p.Arg183Gln | missense_variant | 5/9 | 1 | ENSP00000354314.4 | |||
HAO2 | ENST00000622548.4 | c.509G>A | p.Arg170Gln | missense_variant | 5/9 | 1 | ENSP00000483507.1 | |||
HAO2 | ENST00000457318.5 | c.434G>A | p.Arg145Gln | missense_variant | 4/5 | 3 | ENSP00000393955.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152182Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 250456Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135342
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1461594Hom.: 0 Cov.: 32 AF XY: 0.0000206 AC XY: 15AN XY: 727096
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152182Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74342
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 01, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at